93 related articles for article (PubMed ID: 8164837)
21. Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Joniec I; Ciesielska A; Kurkowska-Jastrzebska I; Przybylkowski A; Czlonkowska A; Czlonkowski A
Brain Res; 2009 Mar; 1261():7-19. PubMed ID: 19401171
[TBL] [Abstract][Full Text] [Related]
22. Chronic L-deprenyl does not alter the restoration of striatal dopamine in MPTP-lesioned mice.
Wiener HL; Hashim A; Lajtha A; Sershen H
J Neurosci Res; 1989 Jul; 23(3):326-9. PubMed ID: 2504936
[TBL] [Abstract][Full Text] [Related]
23. GM1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in MPTP-treated mice.
Schneider JS; Kean A; DiStefano L
J Neurosci Res; 1995 Sep; 42(1):117-23. PubMed ID: 8531220
[TBL] [Abstract][Full Text] [Related]
24. [Therapeutic effect of a natural squamosamide derivative FLZ on Parkinson's disease model mice induced by LPS plus MPTP].
Yu LH; Wei HL; Bao XQ; Zhang D; Sun H
Yao Xue Xue Bao; 2013 Oct; 48(10):1557-62. PubMed ID: 24417082
[TBL] [Abstract][Full Text] [Related]
25. Administration of GM1 ganglioside eliminates neuroleptic-induced sensorimotor deficits in MPTP-treated mice.
Weihmuller FB; Hadjiconstantinou M; Bruno JP; Neff NH
Neurosci Lett; 1988 Oct; 92(2):207-12. PubMed ID: 2903475
[TBL] [Abstract][Full Text] [Related]
26. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
[TBL] [Abstract][Full Text] [Related]
27. Assessment of the role of multidrug resistance-associated proteins in MPTP neurotoxicity in mice.
Plangár I; Zádori D; Szalárdy L; Vécsei L; Klivényi P
Ideggyogy Sz; 2013 Nov; 66(11-12):407-14. PubMed ID: 24555241
[TBL] [Abstract][Full Text] [Related]
28. Persistent depletion of striatal dopamine in mice by m-hydroxy-MPTP.
Fuller RW; Hemrick-Luecke SK
Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):167-72. PubMed ID: 3764080
[TBL] [Abstract][Full Text] [Related]
29. Amine fluorescence histochemical investigation of the striatum in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)-induced parkinsonian mice.
Mizukawa K; Ogawa N; Sora YH
Res Commun Chem Pathol Pharmacol; 1988 Jan; 59(1):121-8. PubMed ID: 3258432
[TBL] [Abstract][Full Text] [Related]
30. Persistent depletion of striatal dopamine in mice by 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine (MTTP).
Fuller RW; Robertson DW; Hemrick-Luecke SK
Biochem Pharmacol; 1986 Jan; 35(2):143-4. PubMed ID: 3484628
[No Abstract] [Full Text] [Related]
31. Amantadine enhances dopamine and serotonin turnover in the MPTP model of Parkinson's disease.
Altagracia M; Rojas P; Kravzov J; Rios C
Proc West Pharmacol Soc; 1993; 36():289-91. PubMed ID: 7690973
[No Abstract] [Full Text] [Related]
32. Ganglioside derivative LIGA20 reduces NMDA neurotoxicity in neonatal rat brain.
Lipartiti M; Lazzaro A; Manev H
Neuroreport; 1992 Oct; 3(10):919-21. PubMed ID: 1421099
[TBL] [Abstract][Full Text] [Related]
33. Riluzole and experimental parkinsonism: antagonism of MPTP-induced decrease in central dopamine levels in mice.
Boireau A; Dubédat P; Bordier F; Peny C; Miquet JM; Durand G; Meunier M; Doble A
Neuroreport; 1994 Dec; 5(18):2657-60. PubMed ID: 7696626
[TBL] [Abstract][Full Text] [Related]
34. Characterization of hepatic microsomal metabolism as an in vivo detoxication pathway of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Chiba K; Kubota E; Miyakawa T; Kato Y; Ishizaki T
J Pharmacol Exp Ther; 1988 Sep; 246(3):1108-15. PubMed ID: 3262153
[TBL] [Abstract][Full Text] [Related]
35. Selenium partially reverses the depletion of striatal dopamine and its metabolites in MPTP-treated C57BL mice.
Khan HA
Neurochem Int; 2010 Nov; 57(5):489-91. PubMed ID: 20619308
[TBL] [Abstract][Full Text] [Related]
36. GM1 ganglioside protects against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse.
Janson AM; Agnati LF; Fuxe K; Cintra A; Sundstrom E; Zini I; Toffano G; Goldstein M
Acta Physiol Scand; 1988 Apr; 132(4):587-8. PubMed ID: 3265839
[No Abstract] [Full Text] [Related]
37. [A mouse model of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced parkinsonism: effect of norepinephrine terminal destruction].
Nishi K; Kondo T; Narabayashi H
No To Shinkei; 1987 Jul; 39(7):663-72. PubMed ID: 3314916
[TBL] [Abstract][Full Text] [Related]
38. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
[TBL] [Abstract][Full Text] [Related]
39. Partially protective effect of amantadine in the MPTP model of Parkinson's disease.
Rojas P; Altagracia M; Kravsov J; Rios C
Proc West Pharmacol Soc; 1992; 35():33-5. PubMed ID: 1502234
[No Abstract] [Full Text] [Related]
40. Differential recovery of sensorimotor function in GM1 ganglioside-treated vs. spontaneously recovered MPTP-treated cats: partial striatal dopaminergic reinnervation vs. neurochemical compensation.
Schneider JS; Schroeder JA; Rothblat DS
Brain Res; 1998 Nov; 813(1):82-7. PubMed ID: 9824674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
